Drug Database
L04AG03 natalizumab
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Tyruko 300 mg concentrate for solution for infusion ▼
- POM Tysabri 300 mg concentrate for solution for infusion (Northern Ireland)
- POM Tysabri 150 mg solution for injection in pre-filled syringe (Northern Ireland)
- POM Tysabri 150 mg solution for injection in pre-filled syringe
- POM TYSABRI 300 mg concentrate for solution for infusion
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).